The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Abstract
AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alcohol use has been shown to increase LVOT obstruction and should be minimized [20][21][22]”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [22]
In the citing paper
“Both the 2024 ACC/AHA and 2023 ESC guidelines give non-dihydropyridine CCBs a class I recommendation for patients in whom β blockers are ineffective or not well tolerated (table 2). 1 22”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [22]
In the citing paper
“Despite a paucity of randomized data, on the basis of data from series and crossover studies, non-vasodilating β blockers and CCBs remain the first line treatments for symptomatic hypertrophic cardiomyopathy.22”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [22]
In the citing paper
“US guidelines primarily take a dichotomized, algorithmic approach, 22 whereas the European guidelines advise use of the HCM Risk-SCD calculator”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [22]
In the citing paper
“The 2024 AHA/ACC guidelines give a class 1 recommendation to the use of CMIs, disopyramide, or SRT in patients who have symptoms despite first line therapy (table 2).22”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [22]
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citationArnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Flagged first, then by citations
Research works printed but not linked: 227
- Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
- Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
- Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
- Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
- RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
- SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
- 10.1016/s0025-6196(11)64198-0 · DOI
- 10.1016/j.jacc.2014.05.003 · DOI · Paper page
- 10.1056/nejmra1710575 · DOI · Paper page
- 10.1161/circulationaha.117.033200 · DOI · Paper page
- 10.1001/jamacardio.2015.0354 · DOI · Paper page
- 10.1056/nejmra1710575 · DOI · Paper page
- 10.1016/j.jacc.2015.01.019 · DOI
- 10.1016/j.jacc.2014.05.003 · DOI · Paper page
- 10.1016/j.jacc.2018.10.007 · DOI
- 10.1016/j.echo.2010.10.006 · DOI
- 10.1161/circulationaha.106.644682 · DOI
- 10.1016/j.amjcard.2017.08.047 · DOI
- 10.1093/ehjci/jew313 · DOI
- 10.1016/j.jacc.2005.02.090 · DOI
- 10.1093/eurheartj/ehz396 · DOI
- 10.1016/j.jacc.2013.02.079 · DOI
- 10.1016/j.jacc.2016.11.063 · DOI
- 10.1161/circulationaha.105.583500 · DOI
- 10.1016/j.jacc.2016.01.071 · DOI
- 10.1016/j.jacc.2012.03.076 · DOI
- 10.1016/j.jacc.2010.11.002 · DOI
- 10.1016/j.echo.2011.03.006 · DOI
- 10.1161/circulationaha.107.698985 · DOI
- 10.1016/j.jcin.2011.02.014 · DOI
- 10.1016/j.amjcard.2007.09.111 · DOI
- 10.1161/01.cir.0000097110.55312.bf · DOI
- 10.1016/j.echo.2010.10.006 · DOI
- 10.1161/circulationaha.106.644682 · DOI
- 10.1016/j.amjcard.2017.08.047 · DOI
- 10.1093/ejechocard/jeq063 · DOI
- 10.1093/ehjci/jew313 · DOI
- 10.1136/hrt.2007.126003 · DOI
- 10.1056/nejmoa021332 · DOI · Paper page
- 10.1016/s0002-9149(99)80416-0 · DOI
- 10.1161/01.cir.0000162460.36735.71 · DOI
- 10.1016/j.jacc.2013.02.079 · DOI
- 10.1161/hcg.0000000000000054 · DOI
- 10.1093/eurheartj/ehq271 · DOI
- 10.1016/j.jacc.2012.02.068 · DOI
- 10.1161/circgen.117.001896 · DOI · Paper page
- 10.1161/circulationaha.114.013478 · DOI
- 10.1093/eurheartj/ehz396 · DOI
- 10.1161/circulationaha.117.033200 · DOI · Paper page
- 10.1016/j.hrthm.2011.07.017 · DOI
- 10.1161/circulationaha.111.090514 · DOI
- 10.1161/circgenetics.116.001620 · DOI
- 10.1161/circulationaha.118.038846 · DOI
- 10.1016/j.jacc.2015.01.019 · DOI
- 10.1161/circulationaha.111.090514 · DOI
- 10.1093/eurheartj/ehz396 · DOI
- 10.1161/circulationaha.118.037264 · DOI
- 10.1161/circulationaha.118.038846 · DOI
- 10.1016/j.jpeds.2017.03.033 · DOI
- 10.1093/eurheartj/ehr092 · DOI · Paper page
- 10.1148/radiol.2018180339 · DOI
- 10.1161/circulationaha.105.583500 · DOI
- 10.1016/j.jacc.2016.11.063 · DOI
- 10.1016/s0735-1097(03)00827-1 · DOI · Paper page
- 10.1161/circep.116.004604 · DOI
- 10.1007/s10554-016-0858-4 · DOI
- 10.1016/j.amjcard.2016.11.010 · DOI
- 10.1016/j.amjcard.2010.01.367 · DOI
- 10.1016/j.jcmg.2016.02.031 · DOI
- 10.1161/circulationaha.113.007094 · DOI · Paper page
- 10.1016/j.jacc.2018.05.060 · DOI
- 10.1136/heartjnl-2013-305471 · DOI
- 10.1016/j.echo.2011.03.002 · DOI
- 10.1016/j.jacc.2015.02.061 · DOI · Paper page
- 10.1161/circulationaha.120.047235 · DOI
- 10.1111/cge.13157 · DOI
- 10.1016/j.hrthm.2019.04.040 · DOI
- 10.1093/europace/euz118 · DOI
- 10.1161/circulationaha.122.062699 · DOI
- 10.1161/circulationaha.120.047235 · DOI
- 10.1001/jamacardio.2019.2861 · DOI
- 10.1001/jamacardio.2018.0789 · DOI
- 10.1016/j.hrthm.2019.04.040 · DOI
- 10.1093/europace/euz118 · DOI
- 10.1177/2047487317702519 · DOI
- 10.1161/circheartfailure.113.000414 · DOI
- 10.1016/j.amjcard.2013.12.034 · DOI
- 10.1111/chd.12286 · DOI
- 10.1093/eurjpc/zwab181 · DOI
- 10.1016/j.jacc.2015.03.552 · DOI
- 10.1111/cge.13157 · DOI
- 10.1016/j.jacc.2016.11.063 · DOI
- 10.1016/j.jjcc.2014.02.011 · DOI
- 10.1007/s10554-016-0858-4 · DOI
- 10.1016/j.amjcard.2016.11.010 · DOI
- 10.1016/j.amjcard.2010.01.367 · DOI
- 10.1016/j.jcmg.2016.02.031 · DOI
- 10.1161/circulationaha.113.007094 · DOI · Paper page
- 10.1016/j.jacc.2018.05.060 · DOI
- 10.1001/jamacardio.2019.1391 · DOI
- 10.1161/circulationaha.105.583500 · DOI
- 10.1136/heartjnl-2013-305471 · DOI
- 10.1016/j.jacc.2020.04.045 · DOI
- 10.1161/circulationaha.119.044366 · DOI · Paper page
- 10.1016/j.jacc.2015.02.061 · DOI · Paper page
- 10.1161/circulationaha.122.062699 · DOI
- 10.1016/s0735-1097(99)00056-x · DOI
- 10.1016/j.amjcard.2010.06.077 · DOI · Paper page
- 10.1056/nejm200006153422403 · DOI
- 10.1016/s0140-6736(00)04005-8 · DOI
- 10.1161/circulationaha.108.798314 · DOI · Paper page
- 10.1016/s0735-1097(03)00827-1 · DOI · Paper page
- 10.1161/circep.116.004604 · DOI
- 10.1017/s1047951105001824 · DOI
- 10.1038/nrcardio.2017.6 · DOI
- 10.1001/jamacardio.2019.1391 · DOI
- 10.1001/jama.298.4.405 · DOI
- 10.1016/j.ahj.2013.06.009 · DOI
- 10.1016/s0735-1097(99)00056-x · DOI
- 10.1161/circulationaha.108.798314 · DOI · Paper page
- 10.1016/j.amjcard.2010.06.077 · DOI · Paper page
- 10.1093/eurheartj/ehq308 · DOI
- 10.1056/nejm200006153422403 · DOI
- 10.1016/j.jacc.2004.12.067 · DOI
- 10.1016/s0140-6736(00)04005-8 · DOI
- 10.1161/circulationaha.105.583500 · DOI
- 10.1016/j.jacc.2016.11.063 · DOI
- 10.1016/j.jjcc.2014.02.011 · DOI
- 10.1016/s0735-1097(03)00827-1 · DOI · Paper page
- 10.1161/circep.116.004604 · DOI
- 10.1136/heartjnl-2013-305471 · DOI
- 10.1093/eurheartj/eht439 · DOI · Paper page
- 10.1016/j.jacc.2020.04.045 · DOI
- 10.1161/circulationaha.119.044366 · DOI · Paper page
- 10.1016/j.jacc.2013.01.037 · DOI
- 10.1177/2047487317702519 · DOI
- 10.1007/s00246-011-9967-y · DOI
- 10.1016/s0735-1097(98)00493-8 · DOI
- 10.1016/j.jacc.2015.03.552 · DOI
- 10.1007/s00246-013-0676-6 · DOI
- 10.1161/circulationaha.115.017633 · DOI
- 10.1161/circulationaha.120.047235 · DOI
- 10.1093/eurjpc/zwab181 · DOI
- 10.1161/circulationaha.113.007094 · DOI · Paper page
- 10.1016/j.jcmg.2016.02.031 · DOI
- 10.1016/j.jacc.2018.05.060 · DOI
- 10.1016/j.amjcard.2013.12.034 · DOI
- 10.1161/circulationaha.112.136085 · DOI · Paper page
- 10.1016/j.jacc.2015.02.061 · DOI · Paper page
- 10.1016/j.amjcard.2020.04.042 · DOI
- 10.1016/j.hrthm.2019.04.040 · DOI
- 10.1016/j.jacc.2009.03.051 · DOI
- 10.1016/j.jacc.2013.01.037 · DOI
- 10.1161/cir.0000000000001063 · DOI · Paper page
- 10.1161/cir.0000000000000628 · DOI · Paper page
- 10.1161/circulationaha.106.644682 · DOI
- 10.1016/j.jacc.2005.02.090 · DOI
- 10.1016/j.jacc.2015.06.1333 · DOI · Paper page
- 10.1161/circulationaha.106.644682 · DOI
- 10.1016/j.jacc.2005.02.090 · DOI
- 10.1016/j.amjcard.2013.01.340 · DOI
- 10.1016/j.jcmg.2013.08.010 · DOI
- 10.1001/jamacardio.2016.0252 · DOI
- 10.1016/j.jtcvs.2018.11.148 · DOI
- 10.1016/j.mayocp.2018.07.022 · DOI
- 10.1016/j.jacc.2016.07.735 · DOI · Paper page
- 10.1016/j.echo.2018.10.011 · DOI
- 10.1136/hrt.2007.118018 · DOI
- 10.1161/circulationaha.117.029267 · DOI · Paper page
- 10.1161/01.cir.0000162460.36735.71 · DOI
- Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
- 10.1536/ihj.27.701 · DOI
- 10.1161/circulationaha.117.033200 · DOI · Paper page
- 10.1161/01.cir.0000097110.55312.bf · DOI
- 10.1161/cir.0000000000001063 · DOI · Paper page
- 10.1161/circulationaha.105.583500 · DOI
- 10.1093/eurheartj/ehq136 · DOI
- 10.1161/circheartfailure.114.002248 · DOI · Paper page
- 10.1253/circj.cj-16-0432 · DOI
- 10.1016/j.amjcard.2017.12.044 · DOI
- 10.1016/s0140-6736(20)31792-x · DOI · Paper page
- 10.1016/j.jacc.2020.04.045 · DOI
- 10.1016/j.ejheart.2008.03.006 · DOI
- Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
- 10.1016/j.jacc.2017.11.040 · DOI
- 10.1093/europace/euw327 · DOI
- Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
- 10.1136/heartjnl-2013-305471 · DOI
- 10.1161/circulationaha.119.044366 · DOI · Paper page
- 10.1161/circheartfailure.114.001843 · DOI · Paper page
- 10.1016/s2213-8587(14)70241-4 · DOI
- 10.1016/j.amjcard.2016.08.092 · DOI
- 10.1111/jce.12982 · DOI
- 10.1161/circulationaha.117.029267 · DOI · Paper page
- 10.1016/j.jacc.2005.01.012 · DOI · Paper page
- 10.1161/jaha.116.005152 · DOI
- 10.1016/j.amjcard.2003.10.025 · DOI
- 10.1016/j.amjcard.2017.12.044 · DOI
- 10.1161/circheartfailure.114.001435 · DOI
- 10.1161/circep.110.957290 · DOI
200 of 227 shown
Cited by
Sorted by citations
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Self-citationFonarow, G. C., Ahmad, F. S., Ahmad, T. A., Albert, N. M., Alexander, K. M., Baker, W. L., Bozkurt, B., Breathett, K. K., Carter, S. J., Cheng, R. K.-H., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.07.007 · Cited by 103
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 101
Self-citationNdumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Self-citation
Metadata
- Authors
- Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
- Affiliations
- American Medical Society for Sports Medicine (US)
- HRS representative.
- Lay stakeholder representative.
- AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
- American Hospital Association (US)
- PACES representative.
- Joint ACC/AHA staff representative.
- ORCID
- Ommen, Steve R.
- Ho, Carolyn Y.
- Asif, Irfan M.
- Balaji, Seshadri
- Burke, Michael A.
- Day, Sharlene M.
- Dearani, Joseph A.
- Ferrari, Victor A.
- Joglar, José A.
- Khan, Sadiya S.
- Kim, Jeffrey J.
- Kittleson, Michelle M.
- Krittanawong, Chayakrit
- Martinez, Matthew W.
- Mital, Seema
- Naidu, Srihari S.
- Saberi, Sara
- Semsarian, Christopher
- Venue
- Circulation
- Published
- 2024-06-04
- Volume
- 149
- Issue
- 23
- Pages
- e1239-e1311
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W4396750647
- Cited by
- 807
- References
- 514
- Citations by year
- 2026: 353 · 2025: 372 · 2024: 82
- FWCI
- 226.55
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-08-19)
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
- MeSH terms
- American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review